ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Financial Overview
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's market cap is currently HK$5.31B. The company's EPS TTM is HK$-0.40756439429999997; its P/E ratio is -7.48; ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
